Notice of Annual General Meeting of Shareholders

* Reuters is not responsible for the content in this press release.

Tue Apr 6, 2010 2:39am EDT 

  LUND, SWEDEN, Apr 06 (MARKET WIRE) -- 


 The Board of Directors of Active Biotech AB (publ) has issued a notice
to the Annual General Meeting, which is to take place at 5 p.m. on
Thursday, May 6, 2010, at the Company's premises at Scheelevagen gen 22
in Lund, Sweden.

    Please see the attached notification, which is being published within
short In Svenska Dagbladet and Post- och Inrikes Tidningar.


 Lund,
April 6, 2010

    ACTIVE BIOTECH AB (PUBL)

    THE BOARD OF DIRECTORS


 
 About Active Biotech

    Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology company
with R&D focus on autoimmune/inflammatory diseases and cancer. Projects
in pivotal phases are laquinimod, an orally administered small molecule
with unique immunomodulatory properties for the treatment of multiple
sclerosis, and ANYARA for use in cancer targeted therapy, primarily renal
cancer. Further key projects in clinical development comprise the three
orally administered compounds TASQ for prostate cancer, 57-57 for SLE and
RhuDexTM for RA.




Active Biotech AB
P.O. Box 724, SE-220 07 Lund
Sweden
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 11 00

    
Active Biotech is obligated to publish the information contained in
this press release in accordance with the Swedish Securities Market Act.
This information was provided to the media for publication on April 6,
2010, at 8:30 a.m.


 
 [HUG#1400601]


 
 
 
  Active Biotech AB Notice
of Annual General Meeting of Shareholders:
http://hugin.info/1002/R/1400601/355855.pdf

    



Copyright 2010, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.